CLINICAL_TRIALS
trial_result
· 2025-12-11
Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA [Phase 2]
Summary
Phase 2 trial results for PP405 in adults with androgenetic alopecia, detailing safety, pharmacokinetics, and efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pelage Pharmaceuticals, Inc. | Conditions: Androgenetic Alopecia | Phase 2 | Status: COMPLETED